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ies with highly polymorphic microsatellite markers suggest that associations can often be detected over disto describe lack of independence in a population between alleles at two closely linked loci. This simple tances of one megabase or more. 5, 6 This fits well with fairly simple methods of estimating how long it takes descriptive term was proposed to replace several terms such as linkage inequality, gametic disequilibrium and an association to decay. For example, the 'half-life' of an association between alleles at loci 1 cM apart is linkage disequilibrium by which the phenomenon had previously been described. 2 The goal of allelic associabout 69 generations or around 2000 years. Association studies have considerable theoretical ation studies of disease is to demonstrate a significantly different distribution of allelic variants in affected and appeal in the analysis of common diseases since they can detect genes that contribute only a relatively small unaffected individuals. There are essentially three possible explanations for this, two of which are scienproportion of the overall liability of developing a disorder. For example, the association between blood tifically interesting. The not so interesting explanation is that the disease association is actually due to popugroup O and duodenal ulcer accounts for little over 1% of the variance in liability. 7 Such a small effect could lation stratification. This occurs when recent admixtures of populations result in both the disease and the only be detected by linkage studies in prohibitively large samples. Risch and Merikangas 8 show that well marker allele occurring at a higher frequency in one component of the population admixture than in over 2000 families are needed to detect a gene with a genotype relative risk of 2 or less using allele-sharing another. Provided that stratification can be excluded, the causes of an association between a marker and a linkage methods. In contrast, the required sample size for an association study is vastly less and is generally disease are likely to be either pleiotropy or the presence of very tight linkage between the marker and a fewer than a thousand which is well within practical limits. The power of association studies to detect genes susceptibility locus. Pleiotropy is the phenomenon whereby a marker has two (or more) properties conof small effect is particularly important since it seems increasingly likely that the majority of psychiatric dissisting of: (a) being detectable as a polymorphism; and (b) having a direct effect on a trait such as susceptiorders reflect the combined action of several or many genes of moderate to small effect (ie oligogenic or polybility to a disease. Linkage detected in families does not usually result in association detected in popugenic inheritance). There are, however, a number of problems with lations. However, tight linkage can result in allelic association with a disease when the marker and a susassociation studies. First, they are limited by the fact the actual disease-causing polymorphism, or one very ceptibility locus are so close together that an association with a particular allele is maintained over many tightly linked to it, must be tested. Thus at the present time such studies are usually conducted using markers generations of recombination. In theory a fourth cause of allelic association is the operation of a common close to or within candidate genes. Unfortunately because we understand very little about the neurobiolselective process at both loci. In practice few examples of this are known in man, but one is the association ogical substrates of most psychiatric disorders, it is rarely possible to specify highly plausible candidates between G6PD deficiency, thalassaemia and resistance to malaria in certain areas of the Mediterranean. 3 (eg APP for familial Alzheimer's disease and PrP for familial prion diseases) and the prior odds against true The physical distance over which detectable allelic association is maintained depends upon a number of association in any experiment are therefore substantial. This is even worse when a non-functional (so-called factors, including the recombination frequency, the number of generations since the second mutational anonymous) polymorphism is studied which is not known to reside in close proximity to a candidate gene. event occurred and attributes of the population such as selection, admixture and rate of population growth, A further problem is that of multiple testing which arises when several polymorphisms are tested and/or as well as factors relating to the study such as the size of the sample and the informativity of the markers.
each polymorphism has multiple alleles. This means that if say 20 patient-control comparisons are made, This is an area that requires more work, but published data on RFLPs suggest that allelic association is detecton average, one 'significant' allelic association will be found even if no true association exists. A conservative able over distances up to 500 kb 4 whereas recent studapproach is to apply the so-called Bonferroni correction and multiply the threshold for statistical signifi-positives, but setting a very stringent test criterion may from each family has been studied. 14 If a case control design has been used then evidence of careful ethnic result in true positives being missed. Therefore it seems preferable to regard the occurrence of some false matching should be sought. On the other hand failures to replicate and negative positives as inevitable and to rely upon replication to identify true positive findings. A partial solution is for studies should be scrutinised carefully too, particularly as regards the issue of power. Many small negative individual groups to attempt their own replication by splitting their sample into two. All markers are tested studies are reported which actually have very little power to detect moderate or small effect sizes. We in the first part but only those satisfying a not too stringent alpha level (say 0.01) are tested in the second. 9 show in Table 1 the approximate sample sizes required to have 80% power of detecting associations with In addition to the study of candidate genes, association studies are likely to be used increasingly to naralleles conferring a range of different relative risks. It can be seen that for relative risks of less than two, samrow down regions of interest after preliminary localisation of a gene by linkage studies. Here it is appropriate ple sizes of several hundred or more are often required depending upon the frequency of the diseaseto use anonymous markers, usually closely-spaced, highly polymorphic microsatellites, but due attention associated allele. For example, an association between schizophrenia and the T102C polymorphism in the must be given to the issue of multiple testing. The prior odds of association in this situation are more difficult 5HT2A receptor gene was recently observed in a large multicentre European collaborative study. 15 A number to gauge, since the presence of linkage does not necessarily imply the presence of association though it will of small 'negative' reports have been published, but we can estimate that the sample needed to replicate this increase the prior odds of association over those in an unlinked region. Once again replication will be finding at the 5% significance level with a power of Ͼ0.80 is about 1000. Indeed meta-analysis of all pubrequired to be sure of an association and individual groups might like to rely upon the split-sample design.
lished data which included over 3000 subjects supports the original finding and suggests that publication Another important problem with traditional casecontrol association studies comes when there is inadbias is unlikely. 16 From the foregoing we can begin to see how we equate matching between the patient and control groups. In this situation it is possible for stratification should respond to conflicting reports where some studies show a significant association between a specific effects to produce either spurious positive or negative results and this is exemplified in publications on polymorphism and a disease whereas others do not. Broadly speaking we need to consider both procedural classical genetic markers in schizophrenia. 10 Other than by ensuring that studies are carried out on homand statistical issues. As far as procedures are concerned particular attention should be paid to the possiogenous populations with good ethnic matching between patients and controls, association studies can bility of population stratification and also the question be carried out on family material consisting of affected individuals and both their parents. In such parent-off- and association unless only a single affected individual of whether there are differences in diagnostic practices, is considered. Thus a risk factor may be neither necessary nor sufficient to cause illness but, if common, sample ascertainment and ethnicity. Of course discrepant results may be real and reflect heterogeneity with result in a substantial number of potential cases passing beyond the threshold for developing the disorder. a genetic risk factor playing a quantitatively or qualitatively different role in different diagnostic or ethnic
The message here then is that the identification of genes of small effect might directly be of therapeutic groups. Also, where the association is based on close linkage, ethnic differences may result from differences importance as well as being essential if we are to build up a complete picture of the pathophysiology of the in allelic association in different populations. This raises the question of what exactly should be classed disorder, itself a prerequisite for rational therapy. What recommendations can we make for the conduct as a 'failure to replicate'. In our view this term should be reserved for studies of the same populations using of association studies in psychiatric genetics? First and most importantly, we must study samples of adequate similar ascertainment and diagnostic practices. The first statistical issue to consider is how statistically sigsize. Power to detect and replicate modest or small effects of the size that are likely to be operating in the nificant are the positive findings? Some appreciation of the prior probability of association is important here, majority of psychiatric disorders requires samples of the order of several hundred to a thousand (Table 1) . though for many psychiatric disorders this is likely to be difficult and based on little more than intuition. The
We believe that inclusion of appropriate power calculations should be a mandatory prerequisite for the pubpower of the negative studies also needs to be considered. In making these judgements greater credence lication of 'negative' association studies. However it is also important that publication bias does not operate should be given to the results of larger studies and there is certainly a place for meta-analysis. This should to prevent the dissemination of negative findings. In this regard we welcome the announcement that Molinclude methods such as funnel plot analysis 17 in order to determine whether publication bias in the form of ecular Psychiatry is to introduce a Scientific Correspondence section to allow the publication of brief selective non-publication of small negative studies is likely to be operating. research reports of complete studies.* There is also a need to identify epidemiologically meaningful samples In an earlier issue the Editor asks what might be the meaning of a statistically significant association, in to allow the size of gene effects to be measured at a population level and also to allow potential interacwhich 60% of individuals with a common psychiatric disorder have a specific polymorphism in a plausible tions with other genes and with environmental factors to be studied. candidate gene in contrast to an overall instance of 35% in the general population. 18 Assuming that such Studies of candidate genes should focus upon polymorphisms that lie within the coding or regulatory a finding is robust (and the stated P value of Ͻ10 −5 is promising!), what, he asks, is the value of such a findregions of the gene and are likely to result in altered structure or expression of the protein. 20 Where associing? In this example the relative risk of disease associated with the polymorphism is approximately 2.8. This ation studies are being conducted to achieve greater localisation within a linked region then highly polysuggests either that the polymorphism itself confers an approximately three-fold increased risk of developing morphic microsatellites are the markers of choice. These should be closely spaced at an interval of 1 cM the disorder or that it is closely linked to a polymorphism which confers a larger risk. In order to resolve or less. Strenuous efforts should be made to reduce the this issue further polymorphisms need to be sought in the area and further association and linkage studies possibility of spurious results due to population stratification. In case control studies the groups should be performed. There may be difficulties in distinguishing the pathogenic variant from other 'hitch-hiking' polycarefully matched for ethnicity and be drawn from the same ethnically homogeneous population. In late onset morphisms that show allelic association with it 19 but once this has been achieved it will provide strong evidisorders the controls and patients should be matched for age since some genes influence longevity. In popudence that the specific gene is indeed involved in conferring susceptibility to the disorder. Given a reasonlations such as the USA where admixutre is a much greater problem than say in Northern Europe, intraably modest relative risk such as this, it is unlikely that detection of this association alone will greatly facilitate familial association studies offer a solution. However, they do not overcome the problem of ethnic differences diagnosis. However, the position might alter as other risk factors are identified. Moreover, it is possible that in disease aetiology or allelic association due to tight linkage. It may therefore be prudent even when an the risk allele might be associated with a particular course or outcome or with response to treatment.
intra-familial design is used, to draw samples from as ethnically a homogeneous population as is possible. It is important to note that a genetic factor that is common in the population can be associated with a Furthermore, in adult onset disorders parent-offspring high attributable risk even though the relative risk may be low. This means that some therapy targetting the *Editor's note: Molecular Psychiatry maintains its editorial policy immediate effects of the risk factor can have quite a of not publishing pilot studies, preliminary data, or case reports. large impact on the disorder at a population level in Scientific correspondence is a new section for brief reports: for spite of the small relative risk. This is intuitively easier more information, please refer to our revised notes for contributors, in this issue of Molecular Psychiatry.
to grasp when the notion of liability-threshold models attention is paid to procedural and statistical issues 
